bpc-157 fda category 2 compounding bpc 157 news bulk drug substances list HHS Secretary RFK Jr. just dropped major news: the FDA is removing 12 peptides from its restrictive Category 2 list — reversing the 2023 Peptides like BPC-157 and TB-500

The two are investigated together because they are studied for complementary mechanisms BPC-157 for moving repair cells and growing new blood vessels at the injury site, and TB-500 for actin regulation and broader cell movement throughout the tissue

Reserve purely systemic injection for situations where local access is difficult or when addressing multiple widespread issues

Only a small percentage of a standard oral dose is absorbed through this active pathway, and that number drops further when digestion is impaired

There are, however, two studies that we can call on: Pentadecapeptide BPC 157 Interactions with Adrenergic and Dopaminergic Systems in Mucosal Protection in Stress (link) This study wasnt designed to find the comparison between two administration methods, but it did look at how different systems of the body would affect these two methods

Most people with ARIA who experience swelling do not have symptoms